Pallister-hall syndrome
Pallister-Hall syndrome
Pallister-Hall syndrome (PHS) is a rare genetic disorder characterized by a wide range of symptoms and physical abnormalities. It is caused by mutations in the GLI3 gene, which plays a crucial role in the development of various body systems during embryonic growth.
Signs and Symptoms[edit | edit source]
Individuals with Pallister-Hall syndrome may exhibit a variety of symptoms, including:
- Polydactyly (extra fingers or toes)
- Hypothalamic hamartoma (a noncancerous tumor in the hypothalamus)
- Bifid epiglottis (a split epiglottis)
- Imperforate anus (absence of an anal opening)
- Kidney abnormalities
- Respiratory distress
- Developmental delay
Genetics[edit | edit source]
Pallister-Hall syndrome is inherited in an autosomal dominant manner, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder. The GLI3 gene mutations responsible for PHS affect the Hedgehog signaling pathway, which is essential for proper embryonic development.
Diagnosis[edit | edit source]
Diagnosis of Pallister-Hall syndrome is based on clinical evaluation, identification of characteristic physical features, and genetic testing to confirm mutations in the GLI3 gene. Prenatal diagnosis is also possible through genetic testing if there is a known family history of the disorder.
Treatment[edit | edit source]
There is no cure for Pallister-Hall syndrome, and treatment is symptomatic and supportive. Management may involve:
- Surgical correction of physical abnormalities such as polydactyly and imperforate anus
- Monitoring and management of hypothalamic hamartoma to prevent complications like seizures
- Supportive therapies for developmental delays and other associated conditions
Prognosis[edit | edit source]
The prognosis for individuals with Pallister-Hall syndrome varies widely depending on the severity of symptoms and the presence of complications. With appropriate medical care and support, many individuals can lead relatively normal lives.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD